PEAK6 Group’s Insys Therapeutics, Inc. INSY Stock Holding History

PEAK6 Group’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-17,850	Closed	-$108K	–	5278
2018 Q1	$108K	Buy	+17,850	New	+$147K	﹤0.01%	3680

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PEAK6 Group's INSY Position: Q2 2018 in Review

PEAK6 Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2018, closing a stake of 17,850 shares — an estimated $108K sold.

PEAK6 Group first reported a position in INSY in Q1 2018 and held it in 1 quarter. The position peaked at $108K in Q1 2018. 103 funds tracked by Wall St. Rank hold INSY as of Q2 2018.

PEAK6 Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
PEAK6 Group sold 17,850 Insys Therapeutics, Inc. shares in Q2 2018, an estimated $108K.
PEAK6 Group first reported a position in Insys Therapeutics, Inc. in Q1 2018 and held it in 1 quarter.
PEAK6 Group's Insys Therapeutics, Inc. position peaked at $108K in Q1 2018.
103 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.